UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
12.47
-0.05 (-0.40%)
At close: Oct 22, 2024, 4:00 PM
12.42
-0.05 (-0.40%)
After-hours: Oct 22, 2024, 5:30 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $525.16 million as of October 23, 2024. Its market cap has increased by 26.58% in one year.
Market Cap
525.16M
Enterprise Value
382.92M
1-Year Change
26.58%
Ranking
Category
Stock Price
$12.47
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $525.16M, an increase of 188.71%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 527.30M | 13.89% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 535.17M |
| Tectonic Therapeutic | 535.01M |
| KalVista Pharmaceuticals | 533.71M |
| Sharecare | 531.78M |
| Cartesian Therapeutics | 529.55M |
| Definitive Healthcare | 524.71M |
| Ginkgo Bioworks Holdings | 522.56M |
| Health Catalyst | 521.86M |